VHI
—
—
Loading…
—
—
MASTER
—
—
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—
ESEN Master AI Score — VHI (Valhi Inc) | As-Of 2026-07-30
| Metric / Component | Grade | Score | Evidence & Commentary | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 52 | Distressed chemicals play with negative earnings, modest valuation floor, modest dividend yield. Turnaround potential constrained by weak profitability and shrinking revenue YoY (-68%). | 6–12M |
| SA Quality/Value Composite | D | 35 | Negative EPS (-$2.54), no P/E, forward P/E of 4.0x suggests heavy loss positioning. Market cap $389M. Quality flags all unfavourable: no profitability, hyper-growth absent, weak balance signals. | 6–12M |
| Zacks Earnings Momentum | F | 18 | YoY earnings growth unavailable; current EPS negative. Revenue contraction (-68% YoY). No earnings date disclosed. Momentum framework suggests deterioration and distress. | 1–3M |
| Institutional & Smart Money Flow | B− | 62 | Volume data gap (avg_volume: 0.00686 appears data encoding issue; treat as low liquidity signal). Beta 0.98 suggests defensive posture. 52-week return −22.8% indicates recent underperformance but may attract contrarian accumulation. | 3–6M |
| Growth Sustainability & Moat | D− | 28 | Revenue declined 68% YoY. No eps_growth_yoy data. Chemicals sector competitive; no disclosed moat indicators (patents, brand, scale advantages). Sustainability outlook poor absent operational turnaround. | 6–12M |
| Valuation & Safety (Pre-Penalty) | C | 58 | Forward P/E 4.0x is compressed but reflects losses. Price $13.75, 52-week range $11.44–$17.77 near lows. Dividend yield 2.35% provides modest income floor. Market cap $389M suggests micro-cap illiquidity risk. | 6–12M |
| Penalty Overlay (Restructuring/Distress Risk) | E | −15 | Negative earnings, falling revenue, micro-cap liquidity, chemical cyclicality. Balance sheet weakness flagged. No visibility on management guidance or turnaround timeline. Restructuring or dividend cut risk elevated. | 1–3M |
| Confidence Score | C | 61 | Data gaps: earnings date, ex-dividend date, TTM revenue, forward guidance missing. Coverage constrained. Finnhub data current but incomplete on fundamentals. Recommend sector-level and company-specific diligence before position sizing. | Ongoing |
| Volatility & Drawdown Risk | C+ | 54 | Beta 0.98 (market-like). 52-week return −22.8%, recent 1-day move +0.88%. Micro-cap status amplifies intraday volatility. Drawdown risk moderate near 52-week low; recovery potential uncertain. | 1–3M |
| Crowding Risk Flag | B | 72 | Low avg volume (encoding anomaly likely) and $389M market cap suggest minimal institutional presence. Retail and distressed-focused buyers may dominate. Low crowding; high idiosyncratic risk. | 3–12M |
Key Snapshot
Current Price
$13.75
52-Week High / Low
$17.77 / $11.44
Forward P/E
4.02x
EPS (TTM)
−$2.54
Dividend Yield
2.35%
Market Cap
$389M
Revenue YoY Change
−68%
Beta
0.98
Peer Context & Sector Positioning
Valhi Inc operates in the Chemicals sector (Chemicals industry). The company is a micro-cap ($389M market cap) with severe profitability headwinds: negative EPS of −$2.54, revenue contraction of 68% YoY, and no disclosed earnings guidance. Within the broader chemicals universe—which includes commodity producers (LyB, APD, ECL) and specialty players—VHI ranks as a distressed turnaround play rather than a quality compounder. Most chemical peers maintain positive earnings and moderate dividend yields; VHI's 2.35% yield masks underlying operational stress. Typical chemicals beta ranges 1.0–1.2; VHI's 0.98 suggests defensive posturing or sector indifference among macro traders. Conclusion: VHI is a high-risk, low-visibility micro-cap outlier, not suitable for growth or yield-focused allocations absent clear operational catalyst.
Horizon Insight: 1–3M vs. 6–12M Outlook
1–3 Month Horizon (Near-term Tactical): Neutral to slightly negative. Recent bounce (+0.88% today) may reflect short-squeeze or rotation into beaten-down names. Near 52-week low ($11.44 support). Micro-cap liquidity and negative earnings offer minimal institutional anchor. Watch for dividend sustainability announcements or management commentary on operational stabilization. Downside risk if revenue contraction accelerates or dividend cut is announced. Probability of negative surprise: ~60%.
6–12 Month Horizon (Medium-term Structural): Conditional recovery only. Valuation (forward P/E 4.0x) offers margin-of-safety IF operational turnaround materializes (e.g., cost restructuring, asset sales, margin recovery). However, 68% revenue YoY decline and no forward guidance suggest distress-driven contraction, not cyclical dip. Chemicals sector cyclicality provides some tailwind if macro conditions improve, but VHI's specific operational challenges must stabilize. Target: IF management credibly signals EBITDA inflection and stabilizes revenue by Q2 2027, upside to $16–18 possible. IF revenue continues to decline, downside to $8–10. Base case: sideways to modest downside ($12–13 range) without catalyst.
FINAL VERDICT
VHI (Valhi Inc): AVOID / HOLD (Institutional Grade: C+, Score 52/100)
Micro-cap chemicals distressed turnaround; negative earnings, 68% revenue YoY collapse, 2.35% dividend yield at risk. Forward P/E 4.0x offers valuation floor but insufficient to offset operational deterioration absent disclosed catalyst. Liquidity, earnings visibility, and balance-sheet weakness elevate restructuring risk. Recommend hold for income believers with high risk tolerance; avoid for core growth/quality mandates. Reassess only upon credible management-driven operational stabilization plan.
Micro-cap chemicals distressed turnaround; negative earnings, 68% revenue YoY collapse, 2.35% dividend yield at risk. Forward P/E 4.0x offers valuation floor but insufficient to offset operational deterioration absent disclosed catalyst. Liquidity, earnings visibility, and balance-sheet weakness elevate restructuring risk. Recommend hold for income believers with high risk tolerance; avoid for core growth/quality mandates. Reassess only upon credible management-driven operational stabilization plan.
52
Rationale: ESEN Master Score of 52/100 (C+ grade) reflects heavily weighted penalties for negative earnings (−$2.54 EPS), severe revenue contraction (−68% YoY), micro-cap illiquidity, and balance-sheet weakness. Modest credit for defensive beta (0.98), low crowding risk, and compressed valuation (4.0x forward P/E). Data gaps on earnings date, TTM revenue detail, and forward guidance further constrain confidence (61/100). Position complexity and distress profile unsuitable for institutional growth or yield strategies absent explicit turnaround thesis with management validation.
Next Steps: (1) Obtain latest 10-Q/10-K for balance-sheet detail and cash burn rate; (2) monitor earnings call for operational commentary and capital allocation plans; (3) reassess dividend sustainability and potential cut risk; (4) track chemicals sector cyclicality as macro leading indicator.
Next Steps: (1) Obtain latest 10-Q/10-K for balance-sheet detail and cash burn rate; (2) monitor earnings call for operational commentary and capital allocation plans; (3) reassess dividend sustainability and potential cut risk; (4) track chemicals sector cyclicality as macro leading indicator.
AI STOCK INSIGHT
VHI Stock Analysis & Forecast
Is VHI a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
VHI Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, VHI shows balanced risk-reward characteristics.
Should You Buy VHI Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in VHI.